相关实验视频

Updated: Sep 15, 2025

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

虚弱指数-实验室对预测COVID-19死亡率的作用:一项前性研究

Elda De Vita¹, Nicola Veronese², Giacomo Guido¹

¹Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of "Aldo Moro", University of Bari "Aldo Moro", Bari, Italy.

Frontiers in public health

|July 17, 2025

概括

虚弱指数实验室 (FI-LAB) 有效预测COVID-19患者的死亡率. 较高的FI-LAB分数与死亡风险增加有显著的相关性,有助于早期识别易受伤害的个体.

科学领域:

老年学是指老年学的学科.
传染性疾病传染性疾病
临床医学临床医学

背景情况:

由于COVID-19的流行病对脆弱个体造成了不成比例的影响,因此需要改进预后工具.
早期识别高风险的COVID-19患者对于优化管理和减少死亡率至关重要.
建议使用虚弱指数实验室 (FI-LAB) 作为潜在的预后指标.

研究的目的:

评估虚弱指数实验室 (FI-LAB) 作为住院COVID-19患者死亡率的预测指标.
评估FI-LAB得分与入院后90天死亡率之间的关联.
确定FI-LAB在识别高风险COVID-19个体中的临床实用性.

主要方法:

分析了2020年3月至2024年2月期间入院的1492名COVID-19患者的队列.
在住院前4天内,使用37个实验室参数计算了虚弱指数-实验室 (FI-LAB) 评分.
用对共变量进行调整的考克斯回归分析来检查FI-LAB与死亡率之间的关系.

主要成果:

在FI-LAB最高三位数 (>0.432) 的患者与最低三位数 (<0.135) 相比,死亡风险增加了17.10倍.
中间FI-LAB得分 (0.135-0.432) 也显示出比最低三位数的死亡风险明显更高.
每增加FI-LAB的0.10点,死亡风险增加近两倍 (HR=1.99,p < 0.0001).

结论:

虚弱指数实验室 (FI-LAB) 是预测住院COVID-19患者死亡率的强大而实用的工具.
实施FI-LAB可以促进早期识别高风险个体,改善患者管理和资源分配.
需要进一步的研究来验证FI-LAB在不同人群和医疗保健环境中的有效性.

关键词:

在 COVID-19 疫情中,虚弱指数-实验室的虚弱指数老化的老化衰老的老化脆弱脆弱脆弱脆弱脆弱死亡率死亡率

更多相关视频

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

Published on: October 6, 2016

相关概念视频

Actuarial Approach

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...